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 Clinic of Gastroenterology and Hepatology, University Hospital Zurich,  Zurich , Switzerland
 
 Introduction 
 Autoimmune pancreatitis (AIP) is a chronic inflam-
matory disease of the pancreas and presents with typical 
clinical, radiological and histopathological characteris-
tics. Although it is often associated with pancreatic infil-
tration by IgG4-positive lymphoplasmacytic cells, there 
are also reports of IgG4-negative AIP patients. In IgG4-
positive patients with AIP, IgG4-positive lymphoplas-
macytic cells are present not only in the pancreas but 
often additionally in other tissues. Therefore, IgG4-pos-
itive AIP is assumed to be part of an IgG4-related disease 
 [1] .
 Most patients present with complaints of jaundice or 
abdominal pain. Less frequently, weight loss or dyspeptic 
symptoms are described  [2–5] . The most important dif-
ferential diagnosis in many cases is pancreatic cancer. In 
patients with AIP, symptoms of other autoimmune dis-
eases may be apparent as well, and diabetes mellitus (DM) 
is frequently present (20–68%)  [5] . Symptoms, however, 
can vary considerably. According to a large international 
multicenter survey, there is a wide variation especially in 
the distribution of jaundice and abdominal pain among 
patients from different parts of the world  [6] . This is also 
the case with other organ involvement, which is reported 
in 15–82% of patients  [6] . Diagnostic work-up is initiated 
mostly for unexplained symptoms of chronic pancreatitis 
or persistently elevated cholestatic blood values. The 
most typical finding on diagnostic imaging is a diffusely 
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or tumour-like enlarged pancreas, with pancreatic calci-
fication or pseudocysts seen rarely  [7, 8] . Other abnor-
malities have been detected in imaging studies of patients 
with symptoms similar to those of chronic pancreatitis. 
In a study comparing the findings on CT of 74 patients 
(25 AIP, 33 pancreatic carcinoma and 16 normal pan-
creas), in addition to diffusely decreased enhancement of 
the pancreas, capsule-like rim and peripancreatic strands, 
pancreatic calcifications (p = 0.04) were more frequently 
detected in AIP patients and therefore were suggested as 
being useful for differentiating AIP from pancreatic can-
cer  [9] .
 Like most autoimmune diseases, AIP responds to ste-
roid therapy  [10] . To avoid unnecessary surgery or diag-
nostic procedures, it is therefore important to consider 
the possibility of AIP at an early stage of patient work-up. 
Until the International Consensus Diagnostic Criteria 
(ICDC) for AIP (online suppl. fig. 1 and 2; for all online 
suppl. material, see www.karger.com/doi/10.1159/000 
437259) were developed, it was difficult to diagnose AIP 
reliably. Despite the availability of ICDC, AIP is under-
diagnosed since physicians seem to be inadequately in-
formed about them and these criteria are not routinely 
used in diagnosis. In order to avoid overlooking the pos-
sibility of pancreatic carcinoma which AIP mimics, diag-
nostic procedures and major surgery may be carried out 
and this might turn out to be unnecessary for this benign 
disease. If ICDC is used, some of these invasive proce-
dures can be avoided. Even if cancer needs to be ruled out, 
once cancer work turns out to be negative, no further re-
peat tests should be performed.
 The aim of this study, therefore, was to evaluate the 
delay in diagnosis of AIP and its consequences in the form 
of essentially unnecessary diagnostic examinations and 
surgical interventions due to the lack of suspicion of AIP.
 Material and Methods 
 The study was approved by the local ethics committee 
 (KEK-ZH-Nr.2010–0332/0).
 Patients 
 A prospective database of patients with AIP has been main-
tained in our department since April 2006. Demographic data, 
symptoms at clinical onset, laboratory and radiological findings, 
as well as treatment and response to it were collected. In patients 
referred to our centre, patient charts were reviewed to complete 
data. Onset of disease was defined as the date of first AIP symp-
toms or the first documentation of laboratory alterations related 
to AIP. Presence or history of other organ involvement, laboratory 
findings and imaging results were recorded.
 Definition of Required/Unnecessary Procedures 
 Indications for all conducted procedures like endoscopic retro-
grade cholangiopancreatography (ERCP) and endoscopic ultra-
sound (EUS) were reviewed. Based on ICDC ( fig. 1 and  2 ;  tables 1 
and  2; all online suppl. material), procedures were defined as re-
quired if diagnosis could not be established as definite by histology 
or imaging, which then required additional work-up to exclude 
pancreatic carcinoma. Imaging results were also labelled as ‘dif-
fuse’, ‘segmental/focal’ or atypical  [11] . If an ERCP was conducted 
for the removal of a stent or drainage placed during a previous en-
doscopic procedure, it was labelled as required if the first proce-
dure had been indicated. However, in those cases in which the first 
procedure was not indicated, the ERCP done to remove a stent or 
drainage also was labelled as unnecessary. Procedures were deemed 
unnecessary if (i) definite diagnosis of AIP was established by 
ICDC and no cancer work-up was required or (ii) they were re-
peated after their initial use yielded negative results in cancer 
work-up. Cancer work-up consisted of EUS with FNA if EUS 
showed some tumor or suspicious region in the pancreas, ERCP as 
well as measurement of CA 19–9.
 Statistical Analysis 
 The Statistical Package for the Social Sciences version 20 (SPSS, 
Chicago, Ill., USA) was used for the statistical analysis. Crude dif-
ferences with respect to unnecessary endoscopic procedures in re-
lation to age, sex, clinical manifestation (jaundice, abdominal pain, 
weight loss), diabetes, other organ involvement, serology as well as 
imaging findings were assessed using the Fisher’s exact test (Fish-
er’s exact test used if strata comprised a sample size  ≤ 5). A multi-
variate logistic regression model was calculated including only fac-
tors that were significant in the univariate analysis to identify risk 
factors for unnecessary endoscopic procedures.
 Results 
 Demographic Data 
 A total of 29 patients with AIP (mean age 56.7 ± 19.4 
years, males: 22 patients (75.9%)) were identified between 
April 2006 and April 2013. The mean duration of symp-
toms prior to diagnosis was 25.6 months. In 19 patients, 
 Fig. 1. Patients with symptoms highly suggestive of AIP and pa-
tients (2) not included in the study. 
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diagnosis was established within 6 months after onset of 
symptoms. The median follow-up time was 19 months 
(range 0–58).
 Clinical Presentation 
 The most common symptoms at original presentation 
were abdominal pain (79.3%), weight loss (55.2%) and 
jaundice (55.2%). Out of 11 patients (37.9%) presenting 
additionally with DM, 7 were newly diagnosed. Two pa-
tients presented with IgG4-related disease with multior-
gan involvement. One presented with infundibulohy-
pophysitis, sicca syndrome, lymphadenopathy and pros-
tatitis with  evidence of lymphocytic infiltration, and the 
other with sclerosing cholangitis, thyreoiditis, DM, sicca 
syndrome and leukocytoclastic vasculitis. A third patient 
presented with AIP in combination with sclerosing chol-
angitis and DM and reported having had similar symp-
toms 27 years earlier. At that time, the patient had been 
diagnosed with interstitial nephritis with histological evi-
dence of lymphoplasmacytic infiltration, which had rap-
idly responded to steroid therapy. Seventeen patients pre-
sented with other organ involvement (58.6%). Because an 
increased prevalence of inflammatory bowel disease 
(IBD) was reported, especially among patients with type 
2 AIP, we evaluated how many of our patients had had a 
a
b
c e
d
 Fig. 2. Atypical imaging findings.  a ,  b Gall 
bladder tumour in patient 1;  c gall bladder 
tumour in patient 2;  d pancreatic calcifica-
tion;  e pancreatic pseudocysts. 
Table 1.  Initial presentation of patients. Symptoms, laboratory al-
terations and extrapancreatic manifestations
Cases, 
n
Frequency, 
%
Symptoms
Abdominal pain 23 79.3
Weight loss 16 55.2
Jaundice 16 55.2
DM 11 37.9
Laboratory alterations
Elevation of IgG4 (>upper 
limit of normal) 23 79.3
Elevation of IgG4 (>2 × upper 
limit of normal) 17 58.6
 Elevation of pancreatic enzymes 14 48.3
Other organ i nvolvement
Biliary tree/gall bladder 14 48.3
Salivary gland 3 10.3
Orbital and lacrimal glands 3 10.3
Lymph nodes 2 6.9
Thyroid gland 1 3.4
Kidneys 1 3.4
Hypophysis 1 3.4
Skin 1 3.4
Prostate 1 3.4
Aorta 1 3.4
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colonoscopy and in how many patients diagnosis of IBD 
was established. In a total of 20 patients for whom data 
were available, it was found that colonoscopy was done 
among 13 patients. In 2 patients, an IBD was diagnosed. 
However, both patients presented with level 1 criteria for 
AIP type 1 and were therefore diagnosed with type 1 AIP. 
Data on clinical presentation and other organ involve-
ment are shown in  table 1 .
 Steroid Treatment and Response 
 Twenty seven of the 29 patients were treated with ste-
roids (93.1%). Two patients were not treated due to prior 
resolution of symptoms in one and surgery in the other 
case. Of the 27 patients treated with steroids, 26 respond-
ed to therapy (96.3%). One patient did not respond and 
this is the patient who committed suicide; it was after-
wards diagnosed histologically that this patient had AIP. 
Of the 27 patients treated with steroids, 14 experienced a 
relapse (51.9%).
 Referrals/Diagnostic Procedures 
 Sixteen patients (55.2%) were referred to our centre 
with suspected pancreatic carcinoma, cholangiocarcino-
ma or carcinoma of the gallbladder (online suppl. table 3). 
It is of interest to note that one-fourth of patients were 
directly referred for surgery either because they com-
Table 2.  Numbers of ERCP and EUS (indicated as well as not indicated)
Patient No. Total number of ERCP 
(inhouse/external)
Number of not 
indicated ERCP 
(inhouse/external)
Total number of EUS 
(inhouse/external)
Number of EUS 
done with FNA
Number of not 
 indicated EUS 
(inhouse/external)
1 2 (1/1) 0 2 (1/1) 1 0
2 2 (1/1) 2 (1/1) 1 (0/1) 1 1
3 1 (1/0) 0 0 0 0
4 0 0 1 (1/0) 1 1 (1/0)
5 0 0 1 (1/0) 0 0
6 4 (1/3) 3 (1/2) 0 0 0
7 0 0 1 (1/0) 1 0
8 2 (0/2) 2 (0/2) 0 0 0
9 0 0 0 0 0
10 0 0 1 (1/0) 1 1 (1/0)
11 7 (7/0) 0 0 0 0
12 1 (0/1) 0 1 (0/1) 1 0
13 4 (0/4) 3 (0/3) 0 0 0
14 0 0 0 0 0
15 0 0 1 (1/0) 1 0
16 3 (3/0) 1 (1/0) 0 0 0
17 0 0 1 (1/0) 1 0
18 2 (0/2) 0 0 0 0
19 1 (0/1) 0 0 0 0
20 3 (3/0) 1 (1/0) 1 (1/0) 1 0
21 2 (1/1) 0 1 (1/0) 1 0
22 0 0 1 (1/0) 0 0
23 4 (0/4) 2 (0/2) 0 0 0
2006–2010 38 14 13 10 3
24 0 0 1 (1/0) 0 0
25 3 (2/1) 1 (1/0) 1 (1/0) 1 0
26 0 0 1 (1/0) 1 1
27 0 0 1 (1/0) 1 0
28 7 (7/0) 5 (5/0) 0 0 0
29 2 (1/1) 0 1 (1/0) 1 0
2011–2012 12 6 5 4 1
Total 50 20 18 14 4
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plained of chronic pain or because they were suspected to 
have cancer (n = 8). Only in 6 of 29 patients (20.7%), AIP 
has already been considered differential diagnosis before 
referral to our clinic. Only 3 of them had presented with 
typical radiological alterations. During follow-up, how-
ever, only 1 of the 29 patients of our study (3.4%) under-
went surgery, due to persisting suspicion of malignant 
tumour, which histology revealed to be false.
 In 31 patients with symptoms highly suggestive of AIP, 
we established the diagnosis of type 1 AIP in 27 patients 
and of type 2 AIP in 2 patient based on ICDC ( fig. 1 and 
algorithm for diagnosis of AIP). In those with type 1 AIP, 
diagnosis was considered definite in 25 or probable in 
2 patients. In the absence of the typical parenchymal find-
ing in imaging (level 1 criterion for AIP; online suppl. 
tables 1–3), 23 patients required work-up for cancer who 
underwent a total of 46 ERCPs and 14 EUS (10 with fine 
needle aspiration (FNA) using a 22 gauge needle). FNA 
was suggestive of AIP only in 1 case; since the cancer 
work-up was negative, 16 of the 46 ERCPs were unneces-
sary. In 5 patients not requiring work-up for cancer, 
4 ERCPs and 4 EUS (all of them with FNA) were per-
formed, all of which were unnecessary. Thus, out of the 
50 ERCPs and 18 EUS performed, 20 ERCPs and 4 EUS 
were unnecessary. In 1 patient, diagnosis could not be es-
tablished using ICDC, but was established histologically 
after suicide. The most frequent reason for an unneces-
sary procedure was the placement/exchange of a drainage 
or stent.
 Taking the year of diagnosis into account, there were 
23 patients diagnosed in 2006–2010 (International diag-
nostic criteria were published in 2011) and 6 patients 
 diagnosed in 2011–2012, as can be seen in  tables 2 and 
 3 .  Among the 23 patients in the early study period, 38 
 ERCPs were performed of which 14 (36.8%) were unnec-
essary. Excluding 1 patient in whom 7 ERCPs were per-
Table 3.  Detailed clinical and imaging characteristics of patients, focus of ERCP
Patient No. Year of 
diagnosis
Jaundice Abdominal 
pain
Imaging Imaging type of AIP Cancer work-up 
 indicated
Focus 
ERCP
1 2006 No Yes Indeterminate Segmental/focal Yes Biliary
2 2007 Yes Yes Typical for AIP Diffuse No Biliary
3 2007 Yes Yes Atypical for AIP None Yes Biliary
4 2008 Yes No Typical for AIP Diffuse No No ERCP
5 2009 No Yes Indeterminate Segmental/focal Yes No ERCP
6 2009 Yes Yes Atypical for AIP None Yes Biliary
7 2009 Yes Yes Indeterminate Segmental/focal Yes No ERCP
8 2009 Yes Yes Typical for AIP Diffuse No Biliary
9 2009 No Yes Atypical for AIP None Yes No ERCP
10 2009 No Yes Typical for AIP Diffuse No No ERCP
11 2009 No Yes Atypical for AIP None Yes Pancreatic
12 2009 No Yes Atypical for AIP None Yes Pancreatic
13 2010 Yes No Atypical for AIP None Yes Biliary
14 2010 Yes Yes Typical for AIP Diffuse No No ERCP
15 2010 No Yes Indeterminate Segmental/focal Yes No ERCP
16 2010 Yes Yes Atypical for AIP None Yes Biliary
17 2010 Yes No Indeterminate Segmental/focal Yes No ERCP
18 2010 No Yes Atypical for AIP None Yes Pancreatic
19 2010 Yes No Atypical for AIP None Yes Biliary
20 2010 Yes Yes Atypical for AIP None Yes Biliary
21 2010 Yes No Indeterminate Segmental/focal Yes Pancreatic
22 2010 No Yes Atypical for AIP None Yes No ERCP
23 2010 Yes Yes Atypical for AIP None Yes Biliary
24 2011 No Yes Indeterminate Segmental/focal Yes No ERCP
25 2011 Yes Yes Atypical for AIP None Yes Biliary
26 2012 No Yes Typical for AIP Diffuse No No ERCP
27 2012 No No Atypical for AIP None Yes No ERCP
28 2012 No Yes Atypical for AIP None Yes Biliary
29 2012 Yes Yes Atypical for AIP None Yes Biliary
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formed due to a very complicate course of disease, there 
were 14 of 31 (45.1%) unnecessary ERCPs in 22 patients. 
Among the 6 patients diagnosed in 2011 and 2012, there 
were 12 ERCPs performed of which 6 (50%) were unnec-
essary.
 There were 2 more patients likely to have had AIP. 
One of them was an 18-year-old girl presenting with 
acute pancreatitis; imaging studies showed that pseudo-
cysts were present in the pancreatic tail even at that 
time. In addition, she had had abdominal pain for 
months before the onset of acute pancreatitis. Rapid re-
sponse to treatment with prednisone together with the 
disappearance of the pseudocyst and abdominal pain 
suggest that the patient had AIP. She did not experience 
a relapse.
 The other patient was a 66-year-old man who present-
ed with DMs, weight loss and abdominal pain. EUS with 
FNA and biopsies of the papilla did not show any typical 
alterations for type 1 AIP. As a malignancy appeared un-
likely in this setting, we started a steroid trial, to which 
this patient too showed good response, suggesting once 
again a diagnosis of AIP. However, AIP could not be es-
tablished in these 2 patients using ICDC, and for this rea-
son, they were excluded from the study.
 Results of univariate analysis comparing patients with 
unnecessary endoscopic procedures with those without 
are shown in  table 4 . There was a significant risk for un-
necessary ERCP in patients with jaundice (OR 9.78, 95% 
CI 1.02–93.50, p = 0.03) as well as for other organ involve-
ment level 1 (OR 6.50, 95% CI 1.05–40.13, p = 0.03). A 
non-significant trend was observed for DMs (OR 0.11, 
95% CI 0.01–1.08, p = 0.05).
 Multivariate analysis, in which only variables with a 
p  ≤ 0.1, as well as age and gender were included, revealed 
jaundice to be a significant risk factor for unnecessary 
ERCP in AIP patients (OR 11.00, 95% CI 1.14–106.43, p = 
0.04).
 Discussion 
 This study with a prospective follow-up highlights the 
problem of diagnosing AIP. Many of our patients do not 
present with the classical clinical presentation of obstruc-
tive jaundice, which might be one reason why the inter-
nationally accepted diagnostic criteria are not routinely 
used. As shown in this study, this may lead to some un-
necessary diagnostic procedures or even pancreatic sur-
geries and costs. Invasive endoscopic investigations such 
as ERCP and EUS may be necessary for ruling out malig-
nancy if level-1 evidence for AIP, namely typical paren-
chymal findings, is indeterminate. However, once cancer 
work-up is proved to be negative, AIP should be taken 
into consideration. In our study, the presence of jaundice, 
raising the red flag of cancer, was a significant risk factor 
for unnecessary endoscopic procedures. There was also a 
trend towards an increased risk of performing additional 
procedures in patients with involvement of bile ducts 
(other organ involvement level 1), which also raises the 
suspicion of possible malignancy. One third of endoscop-
ic procedures were not necessary in our AIP patients.
 The two main reasons for late detection of AIP are the 
fear of pancreatic cancer in the presence of jaundice or a 
tumor like radiologic finding and the wide variety of clin-
ical presentation of this disease entity in European pa-
tients. The typical appearance of AIP, as mainly described 
in the Asian literature, a sausage-like enlarged pancreas 
without focal lesion and jaundice was rarely present in 
our patients. A recent international multicentre survey by 
Kamisawa et al.  [6] compared characteristic features of 
AIP in 731 Japanese, Korean, Taiwanese, Indian, US-
American, German, Italian and British patients. Typical 
alterations in parenchyma on imaging studies, consid-
ered level-1 evidence in ICDC, are frequently missing in 
AIP patients. In the multicentre survey by Kamisawa et 
al.  [6] , diffuse pancreatic swelling was reported in 39–
85% of Asian patients, 57% of US-American patients and 
18–47% of European patients. In our study, diffuse swell-
ing was reported in 20.7% of patients and is therefore 
comparable to the European data mentioned by Kamisa-
wa et al.  [6] . This finding might be due to less frequent 
manifestation of this phenomenon, but may also be due 
Table 4.  Risk factors for unnecessary endoscopic procedures in 
AIP patients
Variable OR 95% CI p value
Age older than 40 1.17 0.18–7.56 0.63
Male gender 1.17 0.18–7.56 0.63
Other organ involvement, level 1 6.50 1.05–40.13 0.03
Other organ involvement, level 2 0.50 0.48–5.24 0.50
Serology, level 1 0.66 0.13–3.19 0.45
Serology, level 2 0.86 0.13–5.56 0.63
Jaundice 9.78 1.02–93.50 0.03
Abdominal pain 1.17 0.18–7.56 0.63
Weight loss 1.02 0.21–4.98 0.65
DM 0.11 0.01–1.08 0.05
Diffuse enlargement in imaging 1.14 0.17–7.76 0.63
Focal enlargement in imaging 0.29 0.03–2.86 0.27
Pancreatic calcifications 2.83 0.45–18.04 0.26
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to underreporting resulting from lack of knowledge of the 
relevance of this radiological finding to the disease and 
has been reported to lead to major surgery in AIP patients 
 [12] . In case of indeterminate or even atypical imaging 
alterations, after excluding pancreaticobiliary cancer, cli-
nicians have to consider AIP. Among our patients, how-
ever, there were neither typical nor indeterminate imag-
ing alterations in 65.5% of patients. In contrast, various 
AIP unspecific findings such as calcifications, pseudo-
cysts or tumour of the gall bladder ( fig. 2 ) were found. 
These findings are described in patients with AIP  [13], 
but as an initial finding it may mislead and prevent AIP 
suspicion.
 Besides imaging, clinical and epidemiological proper-
ties of AIP differed between Asian and European patients: 
whereas the mean age of Asian and US-American pa-
tients varied between 59 and 66.4 years, the European pa-
tients were younger (mean age 37.5 and 57.6 years  [6, 14, 
15] ). In our study, the mean age of patients was 56.7 years. 
Jaundice was the most frequent initial symptom in Asian 
(50–70%) and US-American patients (79%); the initial 
symptoms in European patients were vastly different – 
such as DM, weight loss, and so on. While in Italy (33%) 
and the United Kingdom (64%), clinical signs at onset 
were similarly distributed as in the United States and 
Asia, in Germany and in Switzerland, the most frequent 
clinical finding was abdominal pain in 63 and 79.3%, re-
spectively. However, despite the diversity of clinical 
symptoms of AIP, not abdominal pain (present in 79.3% 
of our patients) but jaundice (present in 55.2% of our pa-
tients) was the risk factor for unnecessary endoscopic 
procedures in our study. This is most likely because jaun-
dice led physicians to suspect the presence of pancreatic 
cancer.
 In Asian and US-American patients, other organ in-
volvement was reported in 33–75% of patients. Among 
European patients, there was an even larger variation. In 
the largest patient cohort from Italy (n = 87), other organ 
involvement was reported in 15% of patients, while in the 
smallest cohort from the United Kingdom (n = 28), it was 
82%  [6] . This, however, might be due to lack of knowl-
edge about other organ involvement in AIP. Other organ 
involvement was seen in 58.6% of patients of our study.
 The proportion of patients presenting with DM in our 
study (38.7%) is in agreement with published data. Most 
of the data on DM in the context of AIP, however, are 
from Asian countries, where rates between 20 and 68% 
have been described  [6, 16] . In one French study, the pro-
portion was 38.6%, while in an Italian study it was 28% 
 [14, 17] . New-onset DM is one of the shared features of 
AIP and pancreatic cancer, which makes differentiating 
AIP from pancreatic cancer even more difficult. Here too, 
it would be useful to keep AIP in mind as a differential 
diagnosis.
 Until the publication of the ICDC for AIP in April 
2011  [18] , no standardized universally accepted crite-
ria  for AIP were available. While in Asia the Japanese, 
 Korean or Asian diagnostic criteria were used, the United 
States, India and the United Kingdom used the revised 
HISORt criteria, Germany used the Mannheim-Criteria 
and Italy the Italian criteria  [17, 19–23] . These criteria 
varied depending on the tests for diagnosing AIP. Endo-
scopic retrograde pancreatogram was a central Asian 
 criterion, while it was not included in Indian or Western 
criteria. Likewise, core biopsy of the pancreas was main-
ly included in the HISORt-criteria. In addition to provid-
ing criteria for diagnosing AIP, the ICDC also include 
former strategies to distinguish it from pancreatic cancer 
 [24–26] . The ICDC are complex, but are comprehensive, 
since they include criteria prioritized by different coun-
tries and therefore make diagnosis of AIP possible in 
countries from different regions by setting up different 
diagnostic patterns. In our study, diagnosis of AIP could 
not be established by the ICDC in 1 patient, but was made 
by histology after the patient committed suicide. Two 
more patients, who we assumed had AIP because they 
responded to steroid therapy, were not included in the 
study because they failed to meet the ICDC. An under- or 
misdiagnosis of AIP might, however, be due to lack of 
knowledge of the ICDC. One major concern regarding 
ICDC is that typical alterations in parenchyma on imag-
ing studies, considered level-1 evidence, are frequently 
missing in AIP patients. In the multicentre survey by 
 Kamisawa et al.  [6] , diffuse pancreatic swelling was re-
ported in 39–85% of Asian patients, 57% of US- American 
patients and 18–47% of European patients. In our study, 
diffuse swelling was reported in 20.7% of patients and is 
therefore comparable to the European data mentioned by 
Kamisawa et al.  [6] . This finding might be due to less fre-
quent manifestation of this phenomenon, but may also 
be due to underreporting resulting from lack of knowl-
edge of the relevance of this radiological finding to the 
disease and has been reported to lead to major surgery in 
AIP patients  [12] . In case of indeterminate or even atyp-
ical imaging alterations, after excluding pancreaticobili-
ary cancer, clinicians have to consider AIP. Among our 
patients, however, there were neither typical nor indeter-
minate imaging alterations in 65.5% of patients. There 
were calcifications, pseudocysts or tumour of the gall 
bladder ( fig. 2 ).
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
5/
27
/2
01
6 
10
:0
8:
36
 A
M
 Unnecessary Procedures and Surgery in 
AIP 
Digestion 2015;92:138–146
DOI: 10.1159/000437259
145
 The number of referrals for suspected pancreaticobili-
ary cancer in our study underlines the lack of knowledge 
of strategies to distinguish AIP from cancer. This prob-
lem was discussed by Kim et al.  [27] , who described that 
in 60% of their patients (10/17) initially a pancreatic ma-
lignancy was suspected. In another study, the pancreatic 
pathologies of 200 surgically treated patients with chron-
ic pancreatitis were reviewed, of whom 53 patients were 
identified to have AIP. Since AIP responds to steroid 
treatment, correct diagnosis could have avoided surgery 
in these patients. Clinically suspected diagnosis leading to 
surgery, however, was carcinoma, carcinoma and/or 
chronic pancreatitis and chronic pancreatitis in 50, 2 and 
1 of the 53 patients, respectively  [15] .
 Our study had certain limitations. The first limitation 
was due to lack of histological evidence, and therefore, 
our data did not enable us to make a clear distinction be-
tween type 1 and 2 AIP in most of our patients. The 2 pa-
tients not included in the analysis might, therefore, have 
been type 2 AIP patients who could not be diagnosed as 
such due to lack of histology. Another limitation was the 
possibility of a referral bias. Nevertheless, we believe that 
our data are comparable to those from literature as re-
ports on AIP have mainly come from other tertiary refer-
ral centres. Due to its rarity, however, it is highly likely 
that AIP will continue to be diagnosed at tertiary referral 
centres. In any case, a tertiary referral centre should be 
involved in the management of patients with unclear 
chronic or recurrent pancreatitis before being referred for 
surgery.
 In conclusion, the features of AIP are essentially simi-
lar in Asia and the United States and are different in 
 Europe. Besides, there is a wide diversity in the way that 
European patients present themselves with AIP. There-
fore, diagnosis of AIP and distinguishing it from pancre-
atic cancer still remains a challenge. Application of the 
ICDC criteria should be propagated among physicians, 
since they enhance the possibility of early diagnosis of 
AIP reliably. A greater awareness of the clinical diversity 
of AIP and routine use of ICDC in diagnosis will enable 
earlier diagnosis of the disease and help avoid unneces-
sary diagnostic procedures and major pancreatic surgery.
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